Cargando…
Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome
OBJECTIVE: Phagocyte-derived myeloperoxidase (MPO) and proinflammatory HDL are associated with metabolic syndrome (MetS) and increased cardiovascular disease risk. Therapeutic lifestyle changes (TLCs), such as a Mediterranean diet and exercise, decrease this risk. However, the link among TLCs, HDL,...
Autores principales: | Mathew, Anna V., Li, Lei, Byun, Jaeman, Guo, Yanhong, Michailidis, George, Jaiswal, Mamta, Chen, Y. Eugene, Pop-Busui, Rodica, Pennathur, Subramaniam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196832/ https://www.ncbi.nlm.nih.gov/pubmed/30201848 http://dx.doi.org/10.2337/dc18-0049 |
Ejemplares similares
-
Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
por: Wang, Guisong, et al.
Publicado: (2018) -
Impaired Amino Acid and TCA Metabolism and Cardiovascular Autonomic Neuropathy Progression in Type 1 Diabetes
por: Mathew, Anna V., et al.
Publicado: (2019) -
Response to Comment on Mathew et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 2018;41:2431–2437
por: Mathew, Anna V., et al.
Publicado: (2019) -
Assessment of Aortic Pulse Wave Velocity and Cardiac Diastolic Function in Subjects With and Without the Metabolic Syndrome: HDL cholesterol is independently associated with cardiovascular function
por: Roes, Stijntje D., et al.
Publicado: (2008) -
Association of Lifestyle Factors With Abdominal Subcutaneous and Visceral Adiposity: The Framingham Heart Study
por: Molenaar, Esther A., et al.
Publicado: (2009)